Endothelial biomarkers (Von willebrand factor, BDCA3, urokinase) as predictors of mortality in COVID-19 patients: cohort study.

导出 OA

翻译打印收藏纠错

作者： Rocío Nayeli,Sánchez-Santillán ^[1] ; Martha Patricia,Sierra-Vargas ^[2] ; Dulce,González-Islas ^[1] ; Octavio Gamaliel,Aztatzi-Aguilar ^[3] ; Rogelio,Pérez-Padilla ^[4] ; Arturo,Orea-Tejeda ^[5] ; Yazmín,Debray-García ^[6] ; Manolo,Ortega-Romero ^[7] ; Candace,Keirns-Davis ^[7] ; Alejandra,Loaeza-Roman ^[1] ; Alejandra,Rios-Pereda ^[7]

作者单位： Heart Failure and Respiratory Distress Clinic, Cardiology Service, Ciudad de México, Mexico. ^[1] Subdivision of Clinical Research, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Ciudad de México, 14080, Mexico. ^[2] Department of Toxicology, CINVESTAV-IPN, Ciudad de México, 07360, Mexico. ^[3] Department of Research on Tobacco and COPD, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Ciudad de México, 14080, Mexico. ^[4] Heart Failure and Respiratory Distress Clinic, Cardiology Service, Ciudad de México, Mexico. oreatart@gmail.com. ^[5] Cardiology Department, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan, 4502 Col Sec XVI, Del Tlalpan CP 14080 , Mexico City, Mexico. oreatart@gmail.com. ^[6] Department of Toxicology and Environmental Medicine Research, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Ciudad de México, 14080, Mexico. ^[7]

关键词 BDCA3 COVID-19 Endothelial dysfunction Mortality SARS-CoV-2 Von Willebrand factor uPA